An analysis of FDA's inspection classification database shows the total number of "Official Action Indicated" classifications for device and drug facilities have declined significantly over the last five years. US-based facilities continued to account for a large share of OAI classifications while China and India's shares remained steady from 2015 to 2019.
OAI classifications for device, drug facilities continue to decline
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.